The Shakti Polytarp IPO is a closed SME Bookbuilding offer (Fresh capital only) that opened on 15 September 2026. The Shakti Polytarp IPO closed on 17 September 2026, with an issue price of ₹59 per share. The Shakti Polytarp IPO has a face value of ₹10 and a lot size of 2,000 shares. The Shakti Polytarp IPO size aggregates up to ₹27 crore, listing on BSE SME on 22 September 2026. The Shakti Polytarp IPO allotment was scheduled for 18 September 2026.
On the financial front, the Shakti Polytarp IPO reported revenue of ₹167 crore for 31 Mar 2025, compared with ₹62 crore for 31 Mar 2024. The Shakti Polytarp IPO PAT was ₹5 crore against ₹1 crore. The Shakti Polytarp IPO EBITDA stood at ₹11 crore with a 8.94% margin. The Shakti Polytarp IPO net worth as of 31 Mar 2025 was ₹18 crore.
Always verify The Shakti Polytarp IPO details and GMP data with the official offer document before investing in the Shakti Polytarp IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2025
31 Mar 2024
31 Mar 2023
Total Assets
71
40
34
Revenue
167
62
46
PAT
5
1
1
EBITDA
11
4
3
Net Worth
18
11
7
Reserves
5
5
3
Total Borrowing
48
23
17
Shakti Polytarp IPO Financials FAQs
Revenue of Shakti Polytarp (Amount in ₹ Crore) — 31 Mar 2025: 167; 31 Mar 2024: 62; 31 Mar 2023: 46. Profit after tax (PAT) — 31 Mar 2025: 5; 31 Mar 2024: 1; 31 Mar 2023: 1.
EBITDA of Shakti Polytarp (Amount in ₹ Crore) — 31 Mar 2025: 11; 31 Mar 2024: 4; 31 Mar 2023: 3. The EBITDA margin is 8.94%.
Total assets — 31 Mar 2025: 71; 31 Mar 2024: 40; 31 Mar 2023: 34. Net worth — 31 Mar 2025: 18; 31 Mar 2024: 11; 31 Mar 2023: 7. Reserves & surplus — 31 Mar 2025: 5; 31 Mar 2024: 5; 31 Mar 2023: 3. (Amount in ₹ Crore)
Total borrowing of Shakti Polytarp (Amount in ₹ Crore) — 31 Mar 2025: 48; 31 Mar 2024: 23; 31 Mar 2023: 17. Debt-to-equity ratio: 2.60.
The financials shown for Shakti Polytarp IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
